Question:
Which of the following is not a method for solubility enhancement:
Which of the following is not a method for solubility enhancement:
Show Hint
When enhancing solubility, consider using co-solvency (using multiple solvents), salt formation (converting the drug into a more soluble salt), or hydrotropy (using a solubilizing agent) rather than crystallization.
Updated On: June 02, 2025
- Crystallization
- Co-solvency
- Salt formation
- Hydrotropy
Hide Solution
Verified By Collegedunia
The Correct Option is A
Solution and Explanation
Crystallization is not a method for solubility enhancement. In fact, crystallization is typically used to purify compounds and reduce solubility in a solvent. In contrast, co-solvency, salt formation, and hydrotropy are methods used to improve the solubility of poorly soluble drugs.
Was this answer helpful?
0
0
Top Questions on Solubility
- Which of the following solvents is having its lowest Ebullioscopic constant?Choose the correct answer from the options given below:
Solvent Boiling Point (K) Chloroform 334.4 Diethyl Ether 307.8 Benzene 353.3 Carbon disulphide 319.4 - CUET (UG) - 2024
- Chemistry
- Solubility
- Which of the following gases at 298 K and 1 atm pressure is having maximum solubility in water?
(A) Methanal, KH = 0.000018
(B) Argon, KH = 40.3
(C) Methane, KH = 0.41
(D) CO2, KH = 1.6
Choose the correct answer from the options given below:- CUET (UG) - 2024
- Chemistry
- Solubility
- The ratio of solubility of AgCl in 0.1 M KCl solution to the solubility of AgCl in water is:
(Given: Solubility product of AgCl = 10−10)- NEET (UG) - 2024
- Chemistry
- Solubility
- If \( P_0 \) and \( P_S \) are the vapour pressures of the solvent and solution respectively and \( X_0 \) and \( X_S \) are mole fractions of solvent and solute respectively, then
- IIITH UGEE - 2024
- Chemistry
- Solubility
- Which of the following is not a method for solubility enhancement:
View More Questions
Questions Asked in GPAT exam
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
- Common name of convective transport
- GPAT - 2025
- Pharmaceutical Analysis
- Which of the following is commonly used as a broad-spectrum preservative in pharmaceutical formulations?
- GPAT - 2025
- Pharmaceutical Analysis
- pH of Jejunum
- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions
